Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers.
Kotsopoulos J, Lubinski J, Moller P, Lynch HT, Singer CF, Eng C, Neuhausen SL, Karlan B, Kim-Sing C, Huzarski T, Gronwald J, McCuaig J, Senter L, Tung N, Ghadirian P, Eisen A, Gilchrist D, Blum JL, Zakalik D, Pal T, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. Kotsopoulos J, et al. Breast Cancer Res Treat. 2014 Feb;143(3):579-86. doi: 10.1007/s10549-013-2823-4. Epub 2014 Jan 24. Breast Cancer Res Treat. 2014. PMID: 24458845
Survival in Norwegian BRCA1 mutation carriers with breast cancer.
Hagen AI, Tretli S, Maehle L, Apold J, Vedå N, Møller P. Hagen AI, et al. Among authors: maehle l. Hered Cancer Clin Pract. 2009 Apr 14;7(1):7. doi: 10.1186/1897-4287-7-7. Hered Cancer Clin Pract. 2009. PMID: 19366445 Free PMC article.
Germline PTEN mutations are rare and highly penetrant.
Rustad CF, Bjørnslett M, Heimdal KR, Mæhle L, Apold J, Møller P. Rustad CF, et al. Among authors: maehle l. Hered Cancer Clin Pract. 2006 Dec 15;4(4):177-85. doi: 10.1186/1897-4287-4-4-177. Hered Cancer Clin Pract. 2006. PMID: 20223021 Free PMC article.
Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers.
Sjursen W, Haukanes BI, Grindedal EM, Aarset H, Stormorken A, Engebretsen LF, Jonsrud C, Bjørnevoll I, Andresen PA, Ariansen S, Lavik LA, Gilde B, Bowitz-Lothe IM, Maehle L, Møller P. Sjursen W, et al. Among authors: maehle l. J Med Genet. 2010 Sep;47(9):579-85. doi: 10.1136/jmg.2010.077677. Epub 2010 Jun 28. J Med Genet. 2010. PMID: 20587412 Free PMC article.
Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study.
Phelan CM, Iqbal J, Lynch HT, Lubinski J, Gronwald J, Moller P, Ghadirian P, Foulkes WD, Armel S, Eisen A, Neuhausen SL, Senter L, Singer CF, Ainsworth P, Kim-Sing C, Tung N, Llacuachaqui M, Chornokur G, Ping S, Narod SA; Hereditary Breast Cancer Study Group. Phelan CM, et al. Br J Cancer. 2014 Jan 21;110(2):530-4. doi: 10.1038/bjc.2013.741. Epub 2013 Nov 28. Br J Cancer. 2014. PMID: 24292448 Free PMC article.
The Norwegian PMS2 founder mutation c.989-1G > T shows high penetrance of microsatellite instable cancers with normal immunohistochemistry.
Grindedal EM, Aarset H, Bjørnevoll I, Røyset E, Mæhle L, Stormorken A, Heramb C, Medvik H, Møller P, Sjursen W. Grindedal EM, et al. Among authors: maehle l. Hered Cancer Clin Pract. 2014 Apr 21;12(1):12. doi: 10.1186/1897-4287-12-12. eCollection 2014. Hered Cancer Clin Pract. 2014. PMID: 24790682 Free PMC article.
108 results